0000000001309365

AUTHOR

Marina Friis

showing 2 related works from this author

Combined treatment of hidradenitis suppurativa with intense pulsed light (IPL) and radiofrequency (RF)

2019

BACKGROUND Hidradenitis suppurativa is a chronic inflammatory disease with high burden. Treatment options are often unsatisfactory. We assessed the effect of a combination therapy of intense pulsed light (IPL) and radiofrequency (RF). METHODS The explorative study included 47 patients and was performed as a prospective, monocentric, randomized, three-arm parallel-group design trial with a prior 12 weeks observation period. Treatment arms were IPL and RF monotherapies or IPL + RF combination therapy. After 12 weeks, all patients received IPL + RF for additional 12 weeks (cross-over). Primary endpoint was the change in active lesion numbers, secondary endpoint the change in Dermatology Qualit…

AdultMalemedicine.medical_specialtyCombination therapymedicine.medical_treatmentDermatologyIntense pulsed lightChronic inflammatory diseaseLesionYoung Adult030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineCombined treatmentmedicineClinical endpointHumansHidradenitis suppurativaProspective Studies030203 arthritis & rheumatologybusiness.industryIntense Pulsed Light TherapyTreatment optionsMiddle AgedRadiofrequency Therapymedicine.diseaseCombined Modality TherapyDermatologyHidradenitis SuppurativaTreatment OutcomeQuality of LifeFemalesense organsmedicine.symptombusinessJournal of Dermatological Treatment
researchProduct

Combined treatment of hidradenitis suppurativa with intense pulsed light (IPL) and radiofrequency (RF)

2019

Background: Hidradenitis suppurativa is a chronic inflammatory disease with high burden. Treatment options are often unsatisfactory. We assessed the effect of a combination therapy of intense pulsed light (IPL) and radiofrequency (RF). Methods: The explorative study included 47 patients and was performed as a prospective, monocentric, randomized, three-arm parallel-group design trial with a prior 12 weeks observation period. Treatment arms were IPL and RF monotherapies or IPL + RF combination therapy. After 12 weeks, all patients received IPL + RF for additional 12 weeks (cross-over). Primary endpoint was the change in active lesion numbers, secondary endpoint the change in Dermatology Qual…

sense organs
researchProduct